Idrisov, Bulat,
Lunze, Karsten,
Cheng, Debbie M.,
Elena Blokhina,
Gnatienko, Natalia,
Quinn, Emily,
Bridden, Carly,
Walley, Alexander Y.,
Bryant, Kendall J.,
Lioznov, Dmitry,
Krupitsky, Evgeny,
Samet, Jefrey H. (2017) suppression). We hypothesized that unhealthy alcohol
use, injection
drug
use, and
opioid craving
SEREDA, Y.,
KIRIAZOVA, T.,
MAKARENKO, O.,
CARROLL, J.J.,
RYBAK, N.,
GILLANI, F.S.,
FLANIGAN, T.,
CHYBISOV, A.,
BENDIKS, S.,
DUTTA, A.,
SAMET, J.H.,
LUNZE, K.,
IDRISOV, B. (2020) Introduction: Co-located treatment for HIV and
opioid use disorder has been shown to improve care
Santomauro, DF,
Herrera, AMM,
Shadid, J,
Zheng, P,
Ashbaugh, C,
Pigott, DM,
Abbafati, C,
Adolph, C,
Amlag, JO,
Aravkin, AY,
Bang-Jensen, BL,
Idrisov, B,
Group Author (2021) Background Before 2020, mental
disorders were leading causes of the global health-related burden
Shnayder, N.A.,
Novitsky, M.A.,
Neznanov, N.G.,
Limankin, O.V.,
Asadullin, A.R.,
Petrov, A.V.,
Dmitrenko, D.V.,
Narodova, E.A.,
Popenko, N.V.,
Nasyrova, R.F. (2022) Background: Patients with schizophrenia have an increased risk of depressive
disorders compared
KAZANTSEVA, A.V.,
DAVYDOVA, YU.D.,
ENIKEEVA, R.F.,
LOBASKOVA, M.M.,
MUSTAFIN, R.N.,
MALYKH, S.B.,
TAKHIROVA, Z.R.,
KHUSNUTDINOVA, E.K. (2020) young adults from Russia. Methods: Depression score was assessed
using Beck Depression Inventory (BDI
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) in the treatment of schizophrenia spectrum
disorders (SSDs). The efficiency of APs is based on a range of target
and the age of the patients. Statistical processing of the obtained material was carried out
using the IBM
YANG, G.,
SUN, J.,
SHI, H.,
ZHAO, S.,
GAREEV, I.,
BEYLERLI, O.,
PAVLOV, V.,
IZMAILOV, A. (2020) RNAs are of great interest as potential noninvasive biomarkers for tumors, lipid
disorders, diabetes mellitus